Your browser doesn't support javascript.
loading
Metabolic, Pharmacokinetic, and Activity Profile of the Liver Stage Antimalarial (RC-12).
Dong, Yuxiang; Sonawane, Yogesh; Maher, Steven P; Zeeman, Anne-Marie; Chaumeau, Victor; Vantaux, Amélie; Cooper, Caitlin A; Chiu, Francis C K; Ryan, Eileen; McLaren, Jenna; Chen, Gong; Wittlin, Sergio; Witkowski, Benoît; Nosten, François; Sriraghavan, Kamaraj; Kyle, Dennis E; Kocken, Clemens H M; Charman, Susan A; Vennerstrom, Jonathan L.
  • Dong Y; College of Pharmacy, University of Nebraska Medical Center, 986125 Nebraska Medical Center, Omaha, Nebraska 68198, United States.
  • Sonawane Y; College of Pharmacy, University of Nebraska Medical Center, 986125 Nebraska Medical Center, Omaha, Nebraska 68198, United States.
  • Maher SP; Center for Tropical and Emerging Global Diseases, University of Georgia, 370 Coverdell Center, 500 D.W. Brooks Drive, Athens, Georgia 30602, United States.
  • Zeeman AM; Department of Parasitology, Biomedical Primate Research Centre, P.O. Box 3306, 2280 GH Rijswijk, The Netherlands.
  • Chaumeau V; Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 68/30 Bantung Road, Mae Sot, Tak 63110, Thailand.
  • Vantaux A; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine Research building, University of Oxford Old Road Campus, Oxford OX3 7DQ, U.K.
  • Cooper CA; Malaria Molecular Epidemiology Unit, Institut Pasteur du Cambodge, 5 Boulevard Monivong, P.O. Box 983, Phnom Penh 120 210, Cambodia.
  • Chiu FCK; Center for Tropical and Emerging Global Diseases, University of Georgia, 370 Coverdell Center, 500 D.W. Brooks Drive, Athens, Georgia 30602, United States.
  • Ryan E; Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia.
  • McLaren J; Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia.
  • Chen G; Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia.
  • Wittlin S; Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia.
  • Witkowski B; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Socinstrasse 57, CH-4002 Basel, Switzerland.
  • Nosten F; Malaria Molecular Epidemiology Unit, Institut Pasteur du Cambodge, 5 Boulevard Monivong, P.O. Box 983, Phnom Penh 120 210, Cambodia.
  • Sriraghavan K; Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 68/30 Bantung Road, Mae Sot, Tak 63110, Thailand.
  • Kyle DE; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine Research building, University of Oxford Old Road Campus, Oxford OX3 7DQ, U.K.
  • Kocken CHM; College of Pharmacy, University of Nebraska Medical Center, 986125 Nebraska Medical Center, Omaha, Nebraska 68198, United States.
  • Charman SA; Center for Tropical and Emerging Global Diseases, University of Georgia, 370 Coverdell Center, 500 D.W. Brooks Drive, Athens, Georgia 30602, United States.
  • Vennerstrom JL; Department of Parasitology, Biomedical Primate Research Centre, P.O. Box 3306, 2280 GH Rijswijk, The Netherlands.
ACS Omega ; 7(14): 12401-12411, 2022 Apr 12.
Article en En | MEDLINE | ID: mdl-35449901
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2022 Tipo del documento: Article